What is it about?
Using the 2021 National Survey on Drug Use and Health data to assess US adults aged 18-64 who used substances in the past 12 months, the shift from DSM-IV to DSM-5 was associated with marked increases in prevalence estimates of common substance use disorders. The DSM-5 approach appears to be particularly useful in identifying mild cases in non-clinical populations which may benefit from timely prevention and brief interventions.
Featured Image
Read the Original
This page is a summary of: 12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use, American Journal of Psychiatry, November 2024, American Psychiatric Association,
DOI: 10.1176/appi.ajp.20231060.
You can read the full text:
Contributors
Be the first to contribute to this page







